Hu, Xin
Fujimoto, Junya
Ying, Lisha
Fukuoka, Junya
Ashizawa, Kazuto
Sun, Wenyong
Reuben, Alexandre http://orcid.org/0000-0003-4510-0382
Chow, Chi-Wan
McGranahan, Nicholas
Chen, Runzhe
Hu, Jinlin
Godoy, Myrna C.
Tabata, Kazuhiro
Kuroda, Kishio
Shi, Lei
Li, Jun
Behrens, Carmen
Parra, Edwin Roger
Little, Latasha D.
Gumbs, Curtis
Mao, Xizeng
Song, Xingzhi
Tippen, Samantha
Thornton, Rebecca L.
Kadara, Humam
Scheet, Paul
Roarty, Emily
Ostrin, Edwin Justin http://orcid.org/0000-0002-4538-6539
Wang, Xu
Carter, Brett W.
Antonoff, Mara B. http://orcid.org/0000-0001-6247-9537
Zhang, Jianhua
Vaporciyan, Ara A.
Pass, Harvey
Swisher, Stephen G. http://orcid.org/0000-0002-3080-1920
Heymach, John V.
Lee, J. Jack http://orcid.org/0000-0001-5469-9214
Wistuba, Ignacio I.
Hong, Waun Ki
Futreal, P. Andrew
Su, Dan
Zhang, Jianjun
Article History
Received: 28 November 2018
Accepted: 23 May 2019
First Online: 5 July 2019
Competing interests
: Dr. Wistuba reports personal fees from Genentech/Roche, Bristol-Myers Squibb, Medscape, Astra Zeneca/Medimmune, Pfizer, Ariad, HTG Molecular, Asuragen, Merck, GlaxoSmithKline, MSD and grants from Genentech, Oncoplex, HTG Molecular, DepArray, Merck, Bristol-Myers Squibb, Medimmune, Adaptive, Adaptimmune, EMD Serono, Pfizer, Takeda, Amgen, Karus, Johnson & Johnson, Bayer, 4D, Novartis and Perkin-Elmer (Akoya), outside the submitted work; Dr. Heymach reports personal fees AstraZeneca, Boehringer Ingelheim, Exelixis, Genentech, GSK, Guardant Health, Hengrui, Lilly, Novartis, Spectrum, EMD Serono, and Synta, grants from AstraZeneca, Bayer, GlaxoSmithKline, Spectrum and Royalties/Licensing fees from Spectrum, outside the submitted work; Dr. Zhang reports personal fees from BMS, AstraZeneca, Geneplus, OrigMed, Innovent, grant from Merck, outside the submitted work. The remaining authors declare no competing interests.